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An Endocytic Pathway Essential for Renal Uptake
and Activation of the Steroid 25-(OH) Vitamin D3
vitamin D3 (Kd of 10210±10212 M) (Haddad et al., 1981;
Haddad, 1995). Due to this tight binding and the high
plasma concentration of DBP (0.3±0.5 mg/ml), virtually
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cused on elucidating the specific mechanisms that de-Denmark
liver 25-(OH) vitamin D3 to this specialized cell type. In6 University of Texas Southwestern Medical Center
particular, the mode of uptake of the steroid and theDallas, Texas 75235
role of DBP in this process is still unclear. According to
the ªfree hormone hypothesis,º it is the free 25-(OH)
vitamin D3 that is taken up into the tubular epithelium.Summary
Uptake is believed to proceed from the basolateral site
of the tubule by yet unknown mechanisms (Mendel,Steroid hormones may enter cells by diffusion through
1989; Haddad, 1995).the plasma membrane. However, we demonstrate
Recently, a major pathway for the uptake of ligandshere that some steroid hormones are taken up by re-
from the luminal site into the proximal tubules was iden-ceptor-mediated endocytosis of steroid-carrier com-
tified. Megalin is a multifunctional clearance receptorplexes. We show that 25-(OH) vitamin D3 in complex expressed in the neuroepithelium and in proximal tubu-
with its plasma carrier, the vitamin D±binding protein,
lar cells of the kidney. The protein shares extensive
is filtered through the glomerulus and reabsorbed in
structural similarities with the low density lipoprotein
the proximal tubules by the endocytic receptor mega-
(LDL) receptor and is a member of the LDL receptor
lin. Endocytosis is required to preserve 25-(OH) vitamin
superfamily (Saito et al., 1994). Like other members of
D3 and to deliver to the cells the precursor for genera- this gene family, megalin exhibits broad ligand specific-
tion of 1,25-(OH)2 vitamin D3, a regulator of the calcium ity and mediates the uptake and lysosomal degradation
metabolism. Megalin2/2 mice are unable to retrieve of numerous macromolecules. Ligands for megalin iden-
the steroid from the glomerular filtrate and develop tified in vitro include lipoproteins, proteases, and prote-
vitamin D deficiency and bone disease. ase inhibitors (Willnow et al., 1992; Moestrup et al., 1995,
1998; Stefansson et al., 1995). The expression of megalin
Introduction on the luminal surface of the tubular epithelium and
its ability to take up ligands injected into the proximal
Vitamin D3 is a steroid hormone that plays an important tubules suggests a role for the receptor in the clearance
role in regulation of the systemic calcium and bone me- of filtered macromolecules (Moestrup et al., 1995, 1996).
tabolism. It is produced in the skin from the precursor The nature of endogenous ligands taken up by megalin
7-dehydrocholesterol and released into the circulation. in vivo remains unclear.
Subsequently, vitamin D3 undergoes two sequential hy- To elucidate the physiological significance of megalin,
droxylation reactions: first in the liver to 25-(OH) vitamin we recently generated mice deficient in the encoding
D3 and then in the kidney to 1,25-(OH)2 vitamin D3. The gene. Most megalin-deficient mice die perinatally from
latter is the active form of the vitamin that acts through holoprosencephaly, a developmental defect of the fore-
binding to nuclear vitamin D receptors expressed in brain (Willnow et al., 1996). The exact causes underlying
various target tissues. In particular, 1,25-(OH)2 vitamin this defect have not been elucidated, but the severity
D3 induces intestinal absorption of calcium from the diet of the phenotype varies among individual animals, and
to increase systemic Ca21 concentrations. 1 in 50 of the megalin2/2 mice survive to adulthood.
Like other steroid hormones, vitamin D3 metabolites Surviving knockout animals were used to study the role
are lipophilic compounds transported in the circulation of the receptor in the renal proximal tubules. Unexpect-
by plasma carrier proteins. The 58 kDa vitamin D±bind- edly, we found that complexes of 25-(OH) vitamin D3
ing protein (DBP) is the principal transporter for vitamin and DBP are filtered through the glomerulus and reab-
D molecules and exhibits highest affinity for 25-(OH) sorbed by megalin into the proximal tubular cells. Abnor-
mal urinary excretion of 25-(OH) vitamin D3 and DBP
in megalin knockout mice results in severe vitamin D7 To whom correspondence should be addressed (e-mail: willnow@
mdc-berlin.de). deficiency and bone disease. Thus, we have identified
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Figure 1. Appearance and Kidney Histology of Wild-Type and Megalin2/2 Mice
(A) Two megalin2/2 mice are shown at 6 weeks of age. Notice facial malformations indicating holoprosencephaly.
(B) Depicted are a megalin2/2 mouse (right) and wild-type littermate.
(C and D) The immunohistochemical detection of megalin (C) and aquaporins (D) in wild-type (1/1) and megalin2/2 kidneys (2/2) is shown.
Semithin cryosections of tissues fixed in 4% paraformaldehyde were incubated with primary antibodies followed by peroxidase-conjugated
secondary antibody. Expression of megalin and aquaporins on the apical surface of the epithelium is indicated by arrows; arrowheads denote
basolateral expression of aquaporins. Bars 5 10 mm.
(E) Electron micrographs of sections through proximal tubules of wild-type and megalin-deficient kidneys are shown. Tissues were fixed in
4% paraformaldehyde and 1% glutaraldehyde, postfixed in OsO4, dehydrated, and embedded in Epon prior to routine sectioning. Arrowheads
indicate dense apical tubules; arrows indicate coated pits. E, endosomes; L, lysosomes. Bars 5 0.25 mm.
a renal uptake pathway that is essential to preserve hypothesis, we analyzed the urine of megalin-deficient
mice by SDS polyacrylamide gel electrophoresis (PAGE)vitamin D metabolites and to deliver the precursor for
generation of 1,25-(OH)2 vitamin D3. and compared it to control samples (Figure 2). No pro-
teins larger than serum albumin (68 kDa) were present
in the urine, demonstrating normal glomerular functionResults
in megalin2/2 animals. However, knockout mice specifi-
cally excreted several low-molecular-weight proteinsUrinary Excretion of Vitamin D±Binding Protein
that were not found in control samples (Figure 2A). Suchin Megalin2/2 Mice
low-molecular-weight proteinuria indicates an inabilityApproximately 2% of megalin knockout animals survive
of the proximal tubules to reabsorb small plasma pro-to adulthood. These animals are severely retarded in
teins filtered through the glomerulus. To identify thesegrowth (Figures 1A and 1B). Superficially, kidneys from
proteins, which are potential ligands for megalin, anthe adult megalin2/2 mice were indistinguishable from
amino-terminal peptide sequence was derived from thethose of wild-type controls. In particular, the lack of
major 58 kDa protein found in knockout urine (Figurereceptor expression in the proximal tubular epithelium
2A). The sequence obtained was identical to the first(Figure 1C) did not affect expression of other cell surface
eight amino acids (L E R G R D Y E) of the mature mouseproteins such as aquaporins (Figure 1D), insulin-like
DBP (Yang et al., 1990). DBP was present exclusivelygrowth factor-II receptor, or ecto-59-nucleotidase (not
in urine from megalin-deficient but not control animalsshown). However, electron microscopical analysis dem-
(Figure 2B).onstrated that components of the endocytic apparatus,
including endosomes, lysosomes, and recycling vesi-
cles (dense apical tubules) were significantly reduced Megalin Is the Renal DBP Receptor
To test directly whether megalin binds DBP, the carrierin number (Willnow et al., 1996). This result suggested
a deficiency in the uptake of filtered macromolecules in was purified from human serum and from urine of pa-
tients with Fanconi syndrome, who are known to excreteproximal tubules lacking megalin (Figure 1E). To test this
Pathway for Activation of 25-(OH) Vitamin D3
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Figure 2. Urinary Protein Profile of Wild-Type and Megalin2/2 Mice
(A) Fifteen microliters of urine from mice of the indicated genotypes
were subjected to 4%±15% nonreducing SDS-PAGE and staining
with Coomassie. Protein bands corresponding to serum albumin
(asterisk) and DBP (arrowhead) are highlighted.
(B) Urine samples as in (A) were subjected to immunoblot analysis
using anti-DBP antiserum and the enhanced chemiluminescence
system (ECL).
DBP (Figure 3A, inset). In BIAcore experiments, urine
and serum DBP bound specifically to megalin with a Kd
of 108 nM 6 62 nM (standard error of the mean, n 5
4) (Figure 3A). Binding was dependent on calcium, a
characteristic feature of ligand binding to LDL receptor±
related receptors. Complexes of DBP and 25-(OH) vita-
min D3 formed in vitro bound to the receptor with similar
affinity as DBP alone (Kd of 111 mm 6 44 mm, n 5 4, Figure 3. Analysis of DBP Binding to Megalin
data not shown). To show that megalin is the only cellular (A) DBP purified from human serum or urine of patients with Fanconi
binding site for DBP in the kidney, cryosections of wild- syndrome was incubated with immobilized megalin in the presence
or absence of 20 mM EDTA. Binding to the receptor was detectedtype mouse kidneys were incubated with purified DBP.
by surface plasmon resonance signal (BIAcore) as described in Ex-Binding of the protein colocalized with megalin on the
perimental Procedures and is indicated in response units. (Inset)apical surface of the proximal tubular cells. No binding
Preparations of DBP from human serum (lane 1) and urine (lane 2)was seen in megalin-deficient kidneys (Figure 3B). When are depicted. DBP was purified by immunoaffinity chromatography
anti-DBP antiserum was added to wild-type kidney sec- using anti-DBP antiserum coupled to CNBr-activated sepharose.
tions, endogenous DBP was detected in endosomes One microgram of DBP was subjected to 10% reducing SDS-PAGE
and lysosomes, indicating uptake from the glomerular and staining with AgNO3.
(B) Cryosections through wild-type and megalin2/2 kidneys werefiltrate. In contrast, no uptake of endogenous DBP was
incubated with purified serum DBP, and cell surface binding ofdetected in knockout kidneys (Figure 3C). The complete
DBP was detected using rabbit anti-DBP antiserum and peroxidase-absence of DBP binding sites and lack of uptake of
conjugated anti-rabbit IgG. Bars 5 10 mm.endogenous DBP in knockout kidneys indicated that
(C) Cryosections through wild-type and megalin2/2 kidneys were
megalin is the only receptor to retrieve the protein from incubated with anti-DBP IgG, followed by peroxidase-conjugated
the glomerular filtrate. anti-rabbit IgG. Arrowheads indicate endogenous DBP present in
endosomes and lysosomes of wild-type kidneys. Bars 5 10 mm.
Megalin Mediates Tubular Uptake of DBP
and 25-(OH) Vitamin D3/DBP Complexes
To show that megalin mediates endocytosis of DBP
from the glomerular filtrate, 125I-DBP was infused into
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Table 1. Uptake of 125I-DBP into Perfused Rat Proximal Tubules
Ligand Percent Renal Uptake (6SEM) n
125I-DBP 75.0 6 11.3 8
125I-DBP 1 RAP 8.2 6 10.4 8
Percent of total radioactivity taken up into proximal tubules is indi-
cated. For details, see Experimental Procedures. n, number of in-
jected tubules; SEM, standard error of the mean.
proximal convoluted tubules of anesthetized rats and
the amount of tubular uptake of the tracer was deter-
mined. In these experiments, a total of 75% of the in-
jected ligand was taken up (Table 1). The internalized
DBP was detected in intracellular vesicles that also con-
tained LAMP1, a lysosomal marker protein, suggesting
that the protein was delivered to lysosomal degradation
(Figure 4A). To show that megalin was responsible for
the endocytosis of DBP, we applied a well-established
antagonist to inhibit megalin activity in the tubules. The
receptor-associated protein (RAP) is a 39 kDa protein
that specifically prevents binding of ligands to LDL re-
ceptor±related receptors and that has been used pre-
viously to block megalin activity in vivo. In these studies,
RAP did not affect other known endocytic receptors in
proximal tubular cells (Moestrup et al., 1995, 1996). By
incubation of wild-type and knockout kidney sections
with radiolabeled RAP, megalin was found to be the only
RAP-binding protein in the kidney (Figures 4B and 4C).
When 125I-labeled DBP was microinfused into proximal
tubules in the presence of RAP, only 8.2% of the ligand
was taken up (Table 1), whereas the remainder was
excreted into the urine. Receptor-mediated uptake and
lysosomal degradation of 125I-DBP was also confirmed
in cultured BN16 choriocarcinoma cells expressing
megalin. In these cells, 18% 6 0.01% of the added
125I-DBP was degraded within 4 hr. Degradation was
inhibited significantly by RAP (3.9% 6 0.01%) or chlo-
roquine (8.3% 6 0.01%). Combined application of both
inhibitors had no additive effect (2.4% 6 0.1% ligand
degraded in 4 hr).
Given the ability of megalin to clear DBP from the
glomerular filtrate, we next tested whether DBP and 25-
(OH) vitamin D3/DBP complexes are continuously fil-
tered through the glomerulus and reabsorbed by this
receptor in the proximal tubules. 125I-labeled DBP was
infused directly into the renal arteries of rats, and the
uptake of radioactivity in kidney, blood, and urine was
determined (see Experimental Procedures). Sixty min-
utes after infusion, 86.5% of the radioactivity was found
in the circulation as proteolytic degradation products
(Table 2). In contrast, when megalin activity was blockedFigure 4. Inhibition of Proximal Tubular Uptake of 125I-DBP by the
Receptor-Associated Protein
(A) Individual rat proximal tubules were microinfused in vivo with 50
nl of phosphate buffer containing 0.5±2.7 pmol 125I-DBP (1000 cpm
total) in the absence or presence of 0.4 mg/ml RAP. The amount of antibodies followed by gold anti-rabbit and anti-mouse IgG. DBP,
tubular uptake of 125I-DBP was determined as depicted in Table 1. large gold particles, large arrowheads; LAMP1, small gold particles,
Then the kidneys were prepared for routine sectioning as in Figure small arrowheads.
1E and the electron micrographs subjected to autoradiography. In (B and C) Semithin cryosections through wild-type (B) and megalin
the absence of RAP, 125I-DBP was detected in apical endosomes of knockout kidneys (C) were incubated with 125I-labeled RAP and sub-
proximal tubular cells (shown). No cellular uptake of 125I-DBP was jected to autoradiography. The arrowheads denote 125I-RAP bound
observed in the presence of RAP (not shown). Bar 5 0.25 mm. (Inset) to the luminal surface of proximal tubular cells in wild-type kidneys
The inset illustrates lysosomal accumulation of DBP by incubation (B). No RAP binding was seen in megalin-deficient kidneys (C).
of ultrathin sections with rabbit anti-DBP and mouse anti-LAMP1 Bars 5 5 mm.
Pathway for Activation of 25-(OH) Vitamin D3
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Table 2. Uptake of 125I-DBP and 3H-25-(OH) Vitamin D3/DBP into Perfused Rat Kidneys
Percent Recovered Ligand (6 SEM)
Ligand t (Min) n Urine Kidney Blood
125I-DBP 60 5 7.6 6 3.3 5.8 6 2.4 86.5 6 5.9
125I-DBP 1 RAP 60 4 84.2 6 7.6 2.4 6 2.0 13.4 6 7.8
3H-25-(OH) D3/DBP 60 5 7.4 6 6.7 7.8 6 4.6 84.6 6 6.2
3H-25-(OH) D3/DBP
1 RAP 10 1 6.8 0.6 92.6
30 2 41.7 6 11 3.8 6 0.6 54.5 6 10.2
60 4 86.1 6 11 0.05 6 0.02 13.9 6 11.2
Percent of total radioactivity recovered in blood, kidney, and urine at the indicated time points after injection of the ligand is shown. For
details, see Experimental Procedures.
n, number of animals; SEM, standard error of the mean; t, perfusion time in minutes.
by coinjection of RAP, only 13.4% of 125I-DBP was de- Vitamin D Deficiency and Bone Formation Defects
in Megalin2/2 Micetected in the plasma, while 84.2% was excreted into
Megalin knockout mice excrete massive amounts ofthe urine. A similar experiment was performed using
DBP in the urine (Figure 2). Because 1% of DBP mole-complexes of 3H-25-(OH) vitamin D3 and unlabeled DBP.
cules in the plasma are found in complex with 25-(OH)To follow the kinetics of glomerular filtration, the ligand
vitamin D3, we reasoned that these animals also losewas allowed one pass (10 min perfusion) or several pas-
significant amounts of the vitamin. We therefore investi-ses (30 or 60 min perfusion) through the kidney (see
gated the consequence of megalin deficiency for vitaminExperimental Procedures). Like 125I-DBP, 3H-25-(OH) vi-
D homeostasis. Western blot analysis demonstratedtamin D3 also appeared in the urine when megalin func-
that DBP levels in the circulation were similar in wild-tion was blocked by coinfusion of RAP (Table 2). The
type and in megalin2/2 mice, demonstrating that theamount of the vitamin excreted correlated directly with
plasma half-life of the protein was unchanged regard-the time of perfusion. Thus, 6.8% of the tracer was fil-
less if it was turned over by tubular degradation in wild-tered per passage through the kidney. After continued
type mice or lost in the urine of knockout mice (Figure 6).perfusion for 60 min, virtually all 3H-25-(OH) vitamin D3
However, urinary excretion of DBP in receptor-deficientwas recovered in the urine (86.1%). When 3H-25-(OH)
animals resulted in the concomitant excretion of 25-vitamin D3 was infused in the absence of RAP, 84.6%
(OH) vitamin D3, which was not present in control urineof the radioactivity was still present in the circulation
(Figure 6). It was calculated that the mice lose 0.3±0.4after 60 min of perfusion. Taken together, these findings
mg DBP and 4±5 ng 25-(OH) vitamin D3 every 24 hr (seeindicated that megalin retrieves DBP and 25-(OH) vita-
Experimental Procedures for details). Most importantly,min D3/DBP complexes from the glomerular filtrate.
urinary loss of the vitamin coincided with an 80% reduc-Prompted by the efficient megalin-mediated uptake
tion in plasma 25-(OH) vitamin D3 levels (Figure 6). Be-of 25-(OH) vitamin D3/DBP complexes, we analyzed
cause plasma levels of 25-(OH) vitamin D3 are an indica-whether this pathway also provided 25-(OH) vitamin D3
tor of bioavailability of the vitamin, this suggested afor hydroxylation. To test for conversion, 3H-labeled vita-
status of vitamin D deficiency in megalin2/2 animals.min D3 metabolites were recovered from blood and urine Similar to patients and animal models with vitamin Dof perfused animals (as in Table 2) and analyzed by high
deficiencies, megalin2/2 mice were characterized by se-pressure liquid chromatography (HPLC). To distinguish
vere bone formation defects. The mice were significantly
between precursors taken up from the glomerular filtrate
retarded in growth (Figures 1A and 1B) and exhibited a
(luminal) or the circulation (basolateral), we used rats dramatic reduction in density of the bones, as shown by
that had been perfused with 3H-25-(OH) D3/DBP in the contact X-ray imaging (Figures 7A and 7B). Histological
presence or absence of RAP for 30 to 40 min. At this evaluation of the vertebral bodies revealed highly irregu-
time point, approximately 40% of 3H-25-(OH) vitamin lar and scalloped bone surfaces compared to control
D3 has been filtered and reabsorbed by the proximal animals (Figures 7C and 7D). The lack of continuity of
tubules. In the presence of RAP, the filtered precursor the bone surfaces in the knockout mice was most likely
molecules were lost in the urine and only nonfiltered a consequence of perforating osteoclastic resorptions
metabolites were available for conversion (Table 2). As occurring in high bone turnover conditions. Finally, dis-
depicted in Figure 5B, the vitamin D3 metabolites recov- turbances in bone metabolism were confirmed by a 3.5-
ered from the circulation of animals infused with tracer fold elevation in mean serum alkaline phosphatase lev-
only were present as 3H-25-(OH) vitamin D3 as well as els (352 vs 106 U/l) and by increased concentrations
3H-1,25 (OH)2 vitamin D3. In contrast, only 3H-25-(OH) of hydroxyproline in the urine (417 vs 193 mmol/l) as
vitamin D3, and no conversion products, were identified compared to control mice.
in plasma or urine of animals coinfused with RAP (Figure
5C). These findings demonstrate that filtered 25-(OH) Discussion
vitamin D3 molecules are hydroxylated and that inactiva-
tion of megalin prevents delivery of the precursor to Our findings demonstrate that complexes of 25-(OH)
vitamin D3 and DBP are filtered through the glomerulustubular cells.
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Figure 6. Quantification of DBP and 25-(OH) Vitamin D3 in Mouse
Plasma and Urine
Fifteen microliters of urine and 0.5 ml of plasma obtained from mice
of the indicated megalin genotypes were subjected to 10% nonre-
ducing SDS-PAGE and immunoblot analysis using anti-DBP antise-
rum and ECL. 25-(OH) vitamin D3 was measured in parallel plasma
and urine samples as described in Experimental Procedures. Where
no number is given, the measurement was below the detection limit
of the assay (,5 nM). *, urine values were obtained on samples
concentrated 30-fold by freeze-drying.
proximal tubular cell lines, uptake of 25-(OH) vitamin D3
was observed when the steroid was added in free form,
while little uptake was seen with complexes of 25-(OH)
vitamin D3/DBP (Keenan and Holmes, 1991). Therefore,
it was hypothesized that in vivo uptake of the precursor
also proceeds by diffusion of the free steroid through
the plasma membrane. DBP was believed to solely regu-
late the amount of free 25-(OH) vitamin D3 available in
the circulation (Mendel, 1989; Haddad, 1995). This hy-
pothesis was confounded by the observation that only
0.003% of 25-(OH) vitamin D3 in the circulation is present
in the free form (0.6 pg/ml plasma), whereas the rest is
bound to DBP or serum albumin (20 ng/ml plasma) (Bikle
et al., 1986). At the same time, approximately 0.3 to 0.5
ng of 25-(OH) vitamin D3 are converted into 1, 25-(OH)2
Figure 5. HPLC Analysis of Vitamin D3 Metabolites in Rat Plasma vitamin D3 by the kidney every day (Bikle et al., 1985).and Urine
The requirement for such massive intake of precursor
Vitamin D3 metabolites were purified from plasma and urine samples strongly argues for additional steroid uptake pathwaysof rats infused with 3H-25-(OH) D3/DBP (B) or 3H-25-(OH) D3/DBP 1
whereby the kidney gains access to the pool of boundRAP (C) and subjected to high pressure liquid chromatography
(HPLC) analysis on C18 reverse-phased column (see Experimental 25-(OH) vitamin D3. Based on our findings, it is likely that
Procedures). Radioactivity recovered in each fraction was expressed megalin-mediated endocytosis constitutes the pathway
as the percentage of total radioactivity recovered (33,000 cpm in for delivery of the complexed precursor. Megalin knock-
[B], 40,000±48,000 cpm in [C]). Representative profiles of individual out mice lose approximately 4±5 ng 25-(OH) vitamin D3animals of each group (six animals per group) are shown. The per-
in the urine over 24 hr (based on data in Figure 6). Incent of radioactivity in the 1,25-(OH)2 vitamin D3 peak (B) varied
wild-type animals, the same amount of 25-(OH) vitaminbetween 10% (30 min perfusion) and 25% (45 min perfusion). Closed
circles indicate blood; open circles indicate urine samples. For com- D3 is taken up into epithelial cells via this receptor path-
parison, the HPLC profile of standard vitamin D3 metabolites is way, corresponding to ten times the amount of precur-
shown in (A). D3, vitamin D3. sor metabolized per day. Besides significant efficiency,
megalin-mediated uptake would also ensure cell type
specificity for the delivery of the precursor. Becauseand reabsorbed in the proximal tubules by the endocytic
receptor megalin. 25-(OH) vitamin D3 molecules taken established proximal tubular cell lines (e.g., LLC-PK1)
express very little megalin (E. I. C. et al., unpublishedup via this receptor pathway are converted into 1,25-
(OH)2 vitamin D3. Malabsorption of 25-(OH) vitamin D3/ observations), this receptor pathway may have been
missed in previous studies.DBP complexes in megalin knockout mice results in
severe vitamin D deficiency and bone formation defects. When megalin activity was blocked by RAP, no con-
version products were recovered from rats infused withPreviously, the role of DBP in the delivery of the 25-
(OH) vitamin D3 to the kidney was unclear. In established 3H-25-(OH) vitamin D3 (Figure 5C). This result indicated
Pathway for Activation of 25-(OH) Vitamin D3
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Figure 7. Bone Structure of Wild-Type and Megalin2/2 Mice
(A and B) Radiographic imaging of wild-type (A) and megalin2/2 littermates at 6 weeks of age (B).
(C and D) Histological analysis of the vertebral bodies of wild-type (C) and megalin2/2 mice (D). Undecalcified Goldner-stained sections were
produced from the vertebral bodies. The arrow denotes irregular bone surfaces due to osteoclastic resorptions in the megalin-deficient mouse
(D) compared to smooth connected cancellous bone surfaces in the control animal (C).
that receptor-mediated uptake from the lumen of the uptake of the free steroid from the circulation. The lim-
ited number (n 5 8) and the small size of megalin2/2proximal tubule delivers precursors for hydroxylation.
Such a role of tubular resorption processes in vitamin animals precluded extensive characterization of electro-
lyte and endocrine parameters [e.g., parathyroid hor-D metabolism is supported by studies in patients with
renal defects. Similar to megalin knockout mice, patients mone and 1, 25-(OH)2 vitamin D3] to answer this question.
Nevertheless, phenotypic analysis of mice geneticallythat suffer from tubular resorption deficiency (Fanconi
syndrome) exhibit vitamin D deficiency and bone dis- deficient for DBP strongly supports a role of megalin
and its ligand DBP in the renal vitamin D3 metabolism.ease (rickets, osteomalacia) (Harrison, 1953). Fanconi
syndrome is caused by various genetic as well as envi- In DBP2/2 mice, the plasma half-life of 25-(OH) vitamin
D3 is markedly reduced and urinary loss of the metaboliteronmental factors (e.g., heavy metal poisoning) and is
characterized by an inability of the proximal tubules to increased. This imbalance results in low plasma levels
of 25-(OH) vitamin D3 and 1,25-(OH)2 vitamin D3 and, asreabsorb filtered macromolecules. One of the proteins
excreted in the urine of Fanconi patients is DBP (Tera- a consequence, in defects of bone metabolism (Cooke
et al., 1997).nishi et al., 1983; Figure 3 inset). Therefore, the distur-
bances in calcium and bone metabolism in these pa- The present study identifies a pathway for renal up-
take and activation of 25-(OH) vitamin D3 involving thetients might be explained in part by the urinary loss of
25-(OH) vitamin D3 bound to the carrier. In addition, St. endocytic receptor megalin. Such a role of tubular endo-
cytic processes in vitamin D homeostasis has not beenJohn et al. (1992) showed that in individuals with various
degrees of renal failure, the glomerular filtration rate was known previously. We propose a model in which megalin
mediates the tubular uptake of the steroid-carrier com-directly correlated with the plasma concentrations of
1,25-(OH)2 vitamin D3. This finding suggests that glomer- plexes filtered through the glomerulus (Figure 8). The
carrier DBP is degraded in lysosomes, while 25-(OH)ular filtration is a prerequisite for the generation of 1,25-
(OH)2 vitamin D3. vitamin D3 is converted into 1,25-(OH)2 vitamin D3 and
resecreted into the circulation. This pathway exhibitsOur results demonstrate that megalin constitutes a
highly efficient pathway for delivery of 25-(OH) vitamin D3 striking resemblance to the cellular uptake of LDL by
the LDL receptor. Both receptors mediate the endocyto-to tubular epithelial cells. These findings do not exclude
other pathways for delivery of the precursor, such as sis of lipid-carrier complexes by binding the apoprotein
Cell
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metabolism reaching far beyond systemic calcium and
bone metabolism.
Experimental Procedures
Materials and Sample Collection
Urine samples from patients with myeloma-associated Fanconi syn-
drome were kindly provided by P. Aucouturier (HoÃ pital de Paris),
vitamin D3 metabolites by A.-M. Kissmeyer (Leo Pharmaceutical,
Copenhagen), anti-aquaporin IgG by S. Nielsen (University of Aar-
hus, Aarhus) and M. Knepper (NIH, Bethesda), anti-megalin antise-
rum by P. Verroust (HoÃ pital Tenon, Paris), and purified megalin by S.
Moestrup (University of Aarhus, Aarhus). Anti-human DBP antiserumFigure 8. Model of Megalin Function in Renal Uptake and Activation
was purchased from DAKO (Hamburg), 3H-25-(OH) vitamin D3 fromof 25-(OH) Vitamin D3
Amersham (Braunschweig). Sterol/DBP complexes were preparedDBP and 25-(OH) vitamin D3/DBP complexes are filtered through the
by incubating purified DBP with a 100-fold molar excess of 3H-25-glomerulus and endocytosed into the proximal tubular epithelium via
(OH) vitamin D3 for 16 hr at 48C under N2 in the dark. Mouse plasmamegalin. The complexes are delivered to lysosomal compartments,
was collected by retroorbital bleeding. For urine collection, micewhere DBP is degraded and the vitamin released into the cytosol.
were placed in metabolic cages for 16 hr and given 10% sucrose25-(OH) vitamin D3 molecules are either secreted directly or hydrox-
in drinking water. Urine samples obtained (approximately 8 ml/24 hr)ylated to 1,25 (OH)2 vitamin D3 prior to release into the interstitial
were qualitatively indistinguishable from samples collected withoutfluid. There, they are complexed by free DBP molecules.
sucrose load. Urine volume per hour and creatinine levels (z6 mg/
dl) were identical in megalin2/2 and in control mice (not shown).
Concentrations of DBP and 25-(OH) vitamin D3 in plasma and urine
moieties (apolipoprotein B-100 or DBP). The apopro- were determined by semiquantitative Western blot analysis (for DBP)
teins are degraded while the steroids [cholesterol or 25- or competitive protein binding assay (for 25-(OH) vitamin D3; Immun-
diagnostik, Bensheim).(OH) vitamin D3] are delivered to the intracellular metab-
olism.
Receptor Binding AssaySimilar to vitamin D metabolites, other steroid hor-
Binding of DBP to megalin was quantified by BIAcore (Biosensor,mones are also transported in the circulation by specific
Sweden) as described previously (Moestrup et al., 1998). A continu-
plasma carrier proteins. These include sex hormone± ous flow of HBS buffer (10 mM HEPES, 3.4 mM EDTA, 150 mM NaCl,
binding globulin and corticosteroid-binding globulin. As 0.005% surfactant P20 [pH 7.4]) passing over the sensor surface
suggested for DBP, these carriers are believed to keep was maintained at 5 ml/min. The carboxylated dextran matrix of the
sensor chip flow cell was activated by injection of 60 ml of a solutionsteroids in a biologically inactive state and regulate the
containing 0.2 M N-ethyl-N9-(3-dimethylaminopropyl)carbodiimideplasma concentration of free hormones that enter cells
and 0.05 M N-hydroxysuccimide in water. Then, 180 ml of 10 mMby diffusion (Siiteri and Simberg, 1986; Mendel, 1989).
sodium acetate (pH 4.5) containing 10 mg/ml purified rabbit megalin
Such a concept requires nonspecific entry of steroids was injected. The remaining binding sites were blocked by subse-
into all cells of an organism in order to find their intracel- quent injection of 35 ml 1 M ethanolamine (pH 8.5). The surface
lular hormone receptors. In contrast, receptor-mediated plasmon resonance signal from immobilized megalin generated
22,000 BIAcore response units (RU) equivalent to 34 fmol megalin/endocytosis of steroid-carrier complexes would offer
mm2. To test DBP binding, rabbit megalin immobilized on CM5 sen-the advantage of cell type±specific delivery. The exis-
sor chip was incubated with 30 mg/ml human DBP in 10 mM HEPES,tence of such uptake pathways for bound steroids was
150 mM NaCl, 1.5 mM CaCl2, 1 mM EGTA (pH 7.4) or in 10 mMproposed because metabolic clearance rates were bet- HEPES, 150 mM NaCl, 20 mM EDTA (pH 7.4), and the relative in-
ter correlated with the total than the free fraction of the crease in response between megalin and control flow channels
hormones, indicating uptake of both free and bound was determined. Kinetic parameters were determined by using the
BIAevaluation 3.0 software.steroids (Siiteri et al., 1982). Furthermore, steroid target
tissues have been shown to express binding sites for
Histological Analysiscarrier proteins (reviews in Siiteri and Simberg, 1986;
The preparation of light and electron microscopical sections of kid-Porto et al., 1995). Finally, endocytosis of testosterone-
ney tissues has been described previously (Christensen et al., 1995).estradiol-binding globulin was demonstrated directly in
For immunolabeling, the sections were incubated with primary anti-
the human breast cancer cell line MCF-7 (Porto et al., bodies either at room temperature for 1 hr or overnight at 48C,
1991). So far, the physiological significance of these followed by incubation with peroxidase-conjugated secondary anti-
body and detection with diaminobenzidine. Binding of DBP and 125I-endocytic pathways for steroid hormone action re-
RAP to kidney sections was carried out as published (Christensenmained unclear. We now report one example for the bio-
et al., 1995). Briefly, the sections were incubated for 30 min withlogical importance of such endocytic pathways (mega-
phosphate buffer containing 100 mM DBP or 1 mCi/ml 125I-RAP.lin) inasmuch as they preserve plasma vitamin D levels
Bound DBP was detected by peroxidase-conjugated anti-DBP anti-
and deliver to the kidney the precursor for generation body and diaminobenzidine. For detection of 125I-RAP, electron mi-
of active 1,25-(OH)2 vitamin D3. Clearly, the resorption crographs were subjected to autoradiography (Christensen et al.,
1995).of filtered vitamin D metabolites in the renal proximal
tubule is unique, as it requires especially efficient uptake
Kidney Uptake Experimentspathways to prevent urinary loss of the vitamins. Never-
Microinfusion assays of proximal convoluted tubules of anesthe-theless, it is intriguing to speculate that similar endocytic
tized Wistar rats have been described previously (Moestrup et al.,mechanisms may exist in other tissues. If confirmed for
1995, 1996). A total of 0.5±2.7 pmol 125I-DBP (in 50 nl) were infused
other hormonal systems, these findings not only have into individual proximal tubules for 2 min in the presence or absence
elucidated a central step in the vitamin D metabolism of 0.4 mg/ml RAP. Subsequently, urine was collected from a urether
catheter for 30 min. Tubular uptake was calculated as the differencebut may change current concepts in steroid hormone
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between trichloroacetic acid±precipitable counts microinfused ver- Harrison, H.E. (1953). The Fanconi syndrome. J. Chron. Dis. 7,
346±355.sus recovered in urine. Perfusion of total rat kidneys was performed
as follows: male Lewis rats fed a diet low in vitamin D and calcium Keenan, M.J., and Holmes, R.P. (1991). The uptake and metabolism
(EF R/M 10 mm, Sniff, Soest) for 6 weeks were anesthetized and of 25-hydroxyvitamin D3 and vitamin D binding protein by cultured
infused with 1% bovine serum albumin in 0.9% NaCl through the porcine kidney cells. Int. J. Biochem. 23, 1225±1230.
external jugular vein to enhance diuresis. The right kidney was Mendel, C.M. (1989). The free hormone hypothesis: a physiologically
clamped, and the aorta was occluded proximal and distal to the left based mathematical model. Endocr. Rev. 10, 232±274.
renal artery. Subsequently, the left kidney was perfused for 10 min
Moestrup, S.K., Cui, S., Vorum, H., Bregengard, C., Bjorn, S.E., Nor-
through a catheter placed in the aorta between the two occlusion
ris, K., Gliemann, J., and Christensen, E.I. (1995). Evidence that
sites with 1 ml of saline containing 50 pM 125I-DBP or 12 ng/ml
epithelial glycoprotein 330/megalin mediates uptake of polybasic3H-25-(OH) vitamin D3 complexed with DBP. Where indicated, the drugs. J. Clin. Invest. 96, 1404±1413.
infusion also contained 1 mg/ml RAP. Under these conditions, the
Moestrup, S.K., Birn, H., Fischer, P.B., Petersen, C.M., Verroust, P.J.,tracer was allowed one pass through the glomerulus (10 min perfu-
Sim, R.B., Christensen, E.I., and Nexo, E. (1996). Megalin-mediatedsion time). For extended filtration, the aorta was repaired and arterial
endocytosis of transcobalamin-vitamin-B12 complexes suggests ablood flow through the kidney restored for 30 or 60 min by opening
role of the receptor in vitamin B12 homeostasis. Proc. Natl. Acad.the proximal occlusion site. Therefore, the entire arterial blood flow
Sci. USA 93, 8612±8617.was directed through the kidney. During the perfusion, urine was
Moestrup, S.K., Schousboe, I., Jacobsen, C., Leheste, J., Chris-collected from the left urether. At the end of the experiment, blood
tensen, E.I., and Willnow, T.E. (1998). b2-glycoprotein-I (apolipopro-was collected from the renal vein effluent, and the total amount of
tein H) and b2-glycoprotein-I-phospholipid complex harbor recogni-radioactivity in urine, blood, and kidney was determined. On aver-
tion site for the endocytic receptor megalin. J. Clin. Invest. 102,age, 60% to 80% of total radioactivity injected was recovered. To
902±909.isolate tritium-labeled vitamin D3 metabolites, the urine and blood
Omdahl, J.L., Hunsaker, L.A., Evan, A.P., and Torrez, P. (1980). Insamples were precipitated with 66% acetonitrile. The supernatant
vitro regulation of kidney 25-hydroxyvitamin D3-hydroxylase enzymewas diluted to 15% acetonitrile and applied to activated C18 car-
activities by vitamin D3 metabolites. J. Biol. Chem. 255, 7460±7466.tridges (SePak, Waters, Milford). The cartridges were washed with
3 ml of 70% methanol and 10 ml H2O. The vitamin metabolites were Porto, C.S., Gunsalus, G.L., Bardin, C.W., Phillips, D.M., and Musto,
N.A. (1991). Receptor-mediated endocytosis of an extracellular ste-then eluted in 4 ml acetonitrile and dried under constant nitrogen
roid-binding protein (TeBG) in MCF-7 human breast cancer cells.flow. Subsequently, the samples were resuspended in 100 ml isopro-
Endocrinology 129, 436±445.panol and chromatographed on C18 reverse-phased column (VYDAC,
#218TP104) in 85% methanol, 15% H2O as published (Omdahl et Porto, C.S., Lazari, M.F.M., Abreu, L.C., Bardin, C.W., and Gunsalus,
al., 1980). Radioactivity was measured in all fractions and expressed G.L. (1995). Receptors for androgen-binding proteins: internalization
as the percentage of total radioactivity recovered. For comparison, and intracellular signaling. J. Steroid Biochem. Mol. Biol. 53, 1±6.
the retention profiles of unlabeled and tritium-labeled vitamin D3 Saito, A., Pietromonaco, S., Loo, A.K.-C., and Farquhar, M.G. (1994).
metabolites were determined. Complete cloning and sequencing of rat gp330/ªmegalin.º A distinc-
tive member of the low density lipoprotein receptor gene family.
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